Kevin Lam

Kevin Lam is an experienced scientist with a strong background in biotechnology and genetic analysis. Currently employed as Scientist II at Capsida Biotherapeutics since June 2020, Kevin has previously held positions at One Lambda, Inc. as a Supervisor and Scientist II from October 2014 to May 2020, where Kevin contributed to the development of high-quality DNA typing products and designed workflows for the Illumina MiSeq platform. Earlier roles include Scientist I at Esoterix and as Lab Technologist Team Leader at National Genetics Institute, where Kevin gained expertise in setting up genetic assays and performing advanced laboratory techniques. Kevin holds a Bachelor's Degree in Biotechnology from California State University, Northridge.